From: French Intensive Care Society, International congress – Réanimation 2016
Variables | All patients (n = 440) |
---|---|
Age [median (IQR)] | 68 (61–74) |
Gender (M/F) | 372/68 |
pH at ICU admission [median (IQR)] | 7.28 (7.23–7.32) |
Time course of COPD (years) [median (IQR)] | 7 (4–15) |
Baseline treatment | |
Aminophylline [n (%)] | 107 (24.3) |
Short-acting β2 mimetics [n (%)] | 197 (44.7) |
Long-acting β2 mimetics [n (%)] | 46 (10.4) |
Inhaled anticholinergics [n (%)] | 39 (8.9) |
Inhaled corticosteroids [n (%)] | 116 (26.4) |
Systemic corticosteroids [n (%)] | 37 (8.4) |